[The effect of liposomal form of L-Dopa on the development of parkinsonian syndrome in mice].
Kucherianu
V G
VG
Iurasov
V V
VV
Kryzhanovskiĭ
G N
GN
Nikushkin
E V
EV
Zhigal'tsev
I V
IV
Kaplun
V P
VP
Shvets
V I
VI
D000818:Animals; D015259:Dopamine Agents / Q000008:administration & dosage*; D004337:Drug Carriers; D007980:Levodopa / Q000008:administration & dosage*; D008081:Liposomes; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000187:drug effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology
D015259:Dopamine Agents; D004337:Drug Carriers; D008081:Liposomes; D007980:Levodopa